Omid Sabzevari

Prof. Omid Sabzevari


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2003 in Human & Experimental Toxicology
Verified
Journal Article
Closed access
PDF file
MAMaryam Akhgari
Maryam Akhgari
MAMohammad Abdollahi
Mohammad Abdollahi
AKAbbas Kebryaeezadeh
Abbas Kebryaeezadeh
RHRuhollah Hosseini
Ruhollah Hosseini
OSOmid Sabzevari
Omid Sabzevari
Organophosphorus compounds may induce oxidative stress leading to generation of free radicals and alterations in antioxidant and scavengers of oxygen free radicals (OFRs). The effect of subchronic exposure to malathion in the production of oxidative stress was evaluated in male Wistar rats. Administration of malathion (100, 316, 1000, 1500 ppm) for 4 weeks increased catalase (CAT), superoxide dismutase (SOD) activities as well as malondialdehyde (MDA) concentration in red blood cells (RBC) and liver. However, acetylcholinesterase (AChE) and cholinesterase (ChE) activities were decreased in these samples. The increase in RBC and liver lipid peroxidation correlated well with the inhibition in RBC AChE and liver ChE activities. Elevation of MDA concentrations and increased activities of CAT and SOD showed significant correlations in both RBC and liver samples when different doses of malathion were used. The results of the present study suggest the usefulness of RBC AChE measurement as a good biomarker in the estimation of malathion-induced oxidative stress affecting blood and liver.

1 May 2010 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
PDF file
MSMojtaba Shakibaie
Mojtaba Shakibaie
MKM.Reza Khorramizadeh
M.Reza Khorramizadeh
MFMohammad Ali Faramarzi
Mohammad Ali Faramarzi
OSOmid Sabzevari
Omid Sabzevari
ASAhmad Reza Shahverdi
Ahmad Reza Shahverdi

4 October 2012 in Pharmaceutical Biology
Verified
Journal Article
Closed access
PDF file
MSMojtaba Shakibaie
Mojtaba Shakibaie
ASAhmad Reza Shahverdi
Ahmad Reza Shahverdi
MFMohammad Ali Faramarzi
Mohammad Ali Faramarzi
GHGholam Reza Hassanzadeh
Gholam Reza Hassanzadeh
HRHamid Reza Rahimi
Hamid Reza Rahimi
OSOmid Sabzevari
Omid Sabzevari
Context: In the present investigation, acute and subacute toxicity of the biogenic Se nanoparticles (Se NPs) has been reported. Objective: To characterize the Se NPs produced by a bacterium species and to evaluate their toxicity and impact on clinical chemistry and hematological parameters of NMRI mice. Materials and methods: The Se NPs were prepared by Bacillus sp. MSh-1 in a culture medium containing SeO2 (1.26 mM) and their physiochemical properties investigated using TEM, XRD and FT-IR. The LD50 of Se NPs and SeO2 were determined and the subacute toxicity evaluated by orally administration of 0, 2.5, 5, 10 and 20 mg kg−1 of Se NPs to male mice for 14 consecutive days. Parameters of blood cells, AST, ALT, ALP, creatinine, BUN, cholesterol, bilirubin, triglyceride and CPK were experimentally measured. Results: The XRD and TEM analyses showed that the spherical NPs were amorphous, in the size range of 80–220 nm. The toxicological evaluation showed that the LD50 values of SeO2 and Se NPs were 7.3 and 198.1 mg kg−1, respectively. No biochemical changes were observed from the administration of 2.5, 5 and 10 mg kg−1 of Se NPs, but a dose of 20 mg kg−1 was accompanied with signs of toxicity including lower body weight and changes in clinical chemistry and hematological parameters. Conclusion: The biogenic Se NPs were less toxic than synthetic Se NPs and much less (26-fold) toxic than the SeO2, which demonstrates the important role of Bacillus sp. MSh-1 in conversion of a highly toxic Se compound to the less toxic Se NPs.

1 November 2002 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
GGGiuseppe Galati
Giuseppe Galati
STShahrzad Tafazoli
Shahrzad Tafazoli
OSOmid Sabzevari
Omid Sabzevari
TCTom S. Chan
Tom S. Chan
POPeter J. O'Brien
Peter J. O'Brien

1 June 2004 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
OSOmid Sabzevari
Omid Sabzevari
GGGiuseppe Galati
Giuseppe Galati
MMMajid Y Moridani
Majid Y Moridani
ASArno Siraki
Arno Siraki
POPeter J O’brien
Peter J O’brien

1 February 2004 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
MNM Nemati
M Nemati
MOM.R Oveisi
M.R Oveisi
HAH Abdollahi
H Abdollahi
OSOmid Sabzevari
Omid Sabzevari